StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
FRNM

Freenome, Inc.

FRNM Nasdaq Services-Medical Laboratories EDGAR ↗
$15.92
-0.27 -1.67%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$142M
Revenue (TTM) ⓘ
—
Net income (TTM) ⓘ
-$763K
EPS (TTM) ⓘ
—
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
—
Cash ⓘ
$437K
Total assets ⓘ
$85.8M
Gross margin ⓘ
—
52-week range ⓘ
$9.95 – $17.50

AI briefing

from the latest 10-K, 10-Q and 8-K events

Freenome, Inc. is a blank check company formed to acquire a healthcare or life sciences business, currently pursuing a proposed business combination with Freenome.

What they do

Freenome, Inc. is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands with no operating revenues. Its activities are limited to identifying and completing an initial business combination, with a focus on North American or European life sciences and medical technology companies. The company held its IPO in June 2024, raising $86.25 million in trust proceeds, and is managed by affiliates of Perceptive Advisors.

Revenue drivers

  • No operating revenues — The company has generated no revenues to date and expects none until a business combination is completed.
  • Trust Account interest income — Interest earned on the $86.25 million trust account is a potential source of funds for operations, but no specific amounts were disclosed in the provided excerpts.

Recent performance

For fiscal year 2025, the company reported net income of $837,468 but operating cash flow of -$864,653. As of June 30, 2026, total assets were $85.8 million, total liabilities $7.1 million, and shareholder equity was -$6.3 million. Cash and equivalents stood at $437,369. The company has no operating history and no revenues.

Strategy

The company intends to focus on healthcare-related industries, particularly life sciences and medical technology, leveraging Perceptive Advisors' network and deal flow. It targets companies ready to be public with competitive advantages and growth opportunities. It is currently pursuing a proposed business combination with Freenome, as referenced in recent filings and 8-K events.

Risks

  • Business combination may not complete — The proposed Freenome business combination may not be completed on the terms or timeline contemplated, or at all, which could lead to liquidation.
  • No operating history and no revenues — The company has no operating history and no revenues, providing no basis for investors to evaluate its ability to achieve its business objective.
  • Redemption risk — Public shareholders may redeem their shares in large numbers, reducing trust account assets and potentially impairing the company's ability to complete a business combination.
  • Going concern uncertainty — The company has negative shareholder equity and limited cash, raising substantial doubt about its ability to continue as a going concern if a business combination is not completed.

Outlook

Management's outlook is centered on consummating the proposed business combination with Freenome before the expiration date. They plan to use the trust account proceeds to fund the combination and may seek additional financing if needed. If the combination is not completed, the company may not be able to find another target and could be forced to liquidate.

Recent SEC filings

40 most recent
Annual, quarterly & current reports
Other filings
SCHEDULE 13G Sep 1, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G Aug 14, 2026
SCHEDULE 13G/A Aug 12, 2026
SCHEDULE 13G/A Aug 12, 2026
SCHEDULE 13G/A Aug 5, 2026